Introduction
The New World screwworm fly (Cochliomyia hominivorax) is a serious pest to livestock in Central and South America, and infestation of animal wounds by screwworm larvae results in a condition called myiasis. [1] In order to eradicate this fly, the sterile male release program was executed successfully in North and Central America. Possible incompatibility of the sex pheromones in released colony flies versus wild flies, however, may cause problems that would render a release program unsuccessful. Clarification of the pheromone system of C. hominivorax is therefore important and urgent. In 1993, Pomonis et al. reported the identification of sixteen compounds in a pheromonally active HPLC fraction extracted from the females of C. homini-antiomerically pure secondary propargylic alcohols in the course of their catalytic hydrogenation to saturated and secondary alcohols, while palladium-charcoal was less potent in causing partial racemization. A new HPLC-based discrimination of chiral and secondary alcohols proved to be useful in following such a subtle partial racemization.
( Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004) vorax.
[1] Unfortunately, however, they were unable to isolate and identify the individual compounds responsible for the pheromone activity.
In 2001, we started a joint project to identify the pheromonally active compounds among Pomonis' sixteen candidates. One of us (D. A. C.) selected five compounds, 1, 2, 3, 4 and 6 (see Scheme 1), as the plausible pheromone candiScheme 1. Structures of the pheromone candidates of the screwworm fly dates, and these were synthesized in 2002 as racemic and diastereomeric mixtures by K. M. and co-workers. [2] Subsequently, 5 was also proposed by D.A.C. as a pheromone candidate. K.M. then synthesized a racemic and diastereomeric mixture of 5 as well as the enantiomers of 6. [3] Bioassay of all the synthetic products on C. hominivorax revealed 1 and 2 to be active as the sex pheromone. [4] Because 1 was more potent than 2 in pheromone activity, we undertook the synthesis of all the possible stereoisomers of 1 for biological evaluation. An important aspect of our project was the precise estimation of the stereochemical purity of the synthetic stereoisomers of 1. Owing to the long distance between the two stereogenic centers of 1, its stereochemical purity was difficult to estimate. The only reliable method for that purpose was Ohrui's analytical protocol for chiral alcohols employing fluorescent and chiral labelling reagents. [5] This paper describes the results of our joint work culminating in the successful synthesis (K.M.), analysis (T.O. and H.O.) and bioassay (D.R.B. and D.A.C.) of the four stereoisomers of 6-acetoxy-19-methylnonacosane (1), all of which showed similar pheromone activity.
Results and Discussion
Since our purpose was to prepare all stereoisomers of 1 with high enantiomeric purity, the synthesis utilized a socalled ''chiral pool'' approach. Scheme 2 shows the retrosynthetic analysis of (6S,19S)-1. The acetate (6S,19S)-1 can be constructed by combining two building blocks A and B, the latter being commercially available (Aldrich, 98% ee). The iodide A can be prepared from (R)-citronellal (7, Takasago, 97% ee).
Scheme 2. Retrosynthetic analysis of (6S,19S)-1

Synthesis and Analysis of (6S,19S)-19-Methylnonacosan-6-ol (16)
For the successful synthesis of the four stereoisomers of 1, we had to develop a route which minimizes the danger of partial racemization in the course of the synthesis. We therefore first synthesized (6S,19S)-19-methylnonacosan-6-ol (16) as summarized in Schemes 3 and 4, and analyzed its stereochemical purity as shown in Scheme 4 and Figure 1 .
Preparation of the methyl-branched alkyl iodide 11 is shown in Scheme 3. (R)-Citronellal (7) was converted into tosylate (S)-8 as reported previously. [6] Under Schlosser conditions in the presence of dilithium tetrachlorocuprate, [7] (S)-8 was coupled with tetrahydropyranyl(THP)oxyheptyl- magnesium bromide to give (S)-9. Removal of the THP protective group of (S)-9 afforded the crystalline alcohol (S)-10. Tosylation of (S)-10 was followed by treatment of the resulting tosylate with sodium iodide to give (S)-11 in 54% overall yield based on (S)-8. Similarly, (R)-11 was prepared from (S)-7.
Another building block, (S)-1-octyn-3-ol (12), was first converted into the corresponding tert-butyldimethylsilyl (TBS) ether (S)-13 as shown in Scheme 4.
Treatment of (S)-13 in THF/HMPA with 1.2 equivalents of n-butyllithium generated the alkynide anion, which was alkylated with (S)-11 to give (6S,19S)-14, whose TBS protective group was removed by treatment with tetra(n-butyl)-ammonium fluoride (TBAF) in THF. The acetylenic alcohol (6S,19S)-15 was obtained in 48% yield based on (S)-11 (2 steps). Hydrogenation of (6S,19S)-15 over Adams' platinum oxide in hexane at room temperature for 2.5 h afforded (6S,19S)-19-methylnonacosan-6-ol (16) as a lowmelting solid, m.p. 35.0Ϫ36.5°C. Acetylation of (6S,19S)-16 furnished (6S,19S)-1, one of the desired target molecules, as an oil.
Needless to say, the product (6S,19S)-1 should have high stereochemical purity if reliable bioassay data is to be obtained. It was therefore important to estimate the stereochemical purity of (6S,19S)-1 in order to check the overall preservation of the stereochemistry in the course of the syn- [5] As shown in Figure 1 , the derived esters 18 were not homogeneous, indicating that the synthetic alcohol (6S,19S)-16 was stereochemically impure. Table 1 shows the HPLC retention times of the four stereoisomers of 18 and also those of 19. They were clearly separated on a tandem series of two reversed-phase columns (Develosil C30-UG-3) cooled to Ϫ30°C (for 18) or Ϫ40°C (for 19). HPLC analysis of the esters 18 derived from (6S,19S)-16 allowed us to estimate the enantiomeric purity of the starting alcohol 16 as 72% ee at C-6 and 97% ee at C-19. The low enantiomeric purity at C-6 must be the result of partial racemization at a certain stage in converting (S)-13 (98% ee) to (6S,19S)-16. We thought that the racemization was caused by addition of a small excess of n-butyllithium to (S)-13 to generate the alkynide anion. The excess base might have abstracted the proton at C-3 of (S)-13, which would have led to partial racemization. Another possible cause of racemization was the hydrogenation step (15 Ǟ 16), but at this stage we assumed it to be less important than the effect of the excess base.
Synthesis of the Four Stereoisomers of 6-Acetoxy-19-methylnonacosane (1)
In order to avoid racemization at C-3 of (S)-13, we decided to employ the dianion derived from (S)-12 for its alkylation with (S)-11. Under the conditions for formation of the dianion of (S)-12 by its treatment with n-butyllithium, there must be no anion formation at C-3 of (S)-12 to give a trianion. We therefore prepared the four stereoisomers of acetylenic alcohol 15 by dianion alkylation as shown in Scheme 5. Hydrogenation of 15 over Adams' platinum oxide was allowed to continue for only 15 min, and the product 16 was acetylated to give the desired four stereoisomers of the acetate 1. It should be noted that (6S,19R)-16 and (6R,19S)-16 showed higher melting points (56Ϫ57°C and 55Ϫ56°C, respectively) than those (37Ϫ38°C and 34Ϫ35°C
, respectively) of (6S,19S)-16 and (6R,19R)-16. The stereoisomers of 1 or 16 could not be distinguished from each other by spectroscopic methods including 300 MHz 1 H NMR, because their two stereogenic centers are separated by twelve carbon atoms. lation are shown in Table 2 . The results indicated that both (6S,19R)-and (6R,19S)-16 were virtually pure at both stereogenic centers. The other two isomers (6S,19S)-and (6R,19R)-16, however, were partially racemized at C-6 to give products of 93.5% ee and 90% ee at C-6, respectively. Since the dianion alkylation method for preparation of 16 cannot accompany racemization at C-6, 3 to 5% inversion at C-6 of (6S,19S)-and (6R,19R)-16 must have been brought about by partial racemization in the course of hydrogenation.
This possibility was examined by comparing the results of the HPLC analysis of 19 derived from acetylenic alcohols 15 and that of 18 derived from the hydrogenation products 16 (Table 3) . While 5% palladium-charcoal (Wako Pure Chemicals Co.) did not cause any appreciable racemization at C-6, Adams' platinum oxide (Kojima Chemical Co.) caused partial racemization after 3 h of hydrogenation at room temperature. When the reaction time with platinum catalyst was shortened to 15 min, the degree of racemization at C-6 became almost negligible. Table 3 . Partial racemization at C-6 in the course of catalytic hydrogenation of 19-methylnonacos-7-yn-6-ol (15) to 19-methylnonacosan-6-ol (16) as analyzed by HPLC after derivatization [a] [a] HPLC analysis was done after derivatizing 15 and 16 with (1S,2S)-17 and (1R,2R)-17 to give 18 and 19.
[b] PtO 2 : Kojima Chemical Co. 5% Pd-C: Wako Pure Chemical Co.
It is widely accepted that platinum oxide catalyst is less prone than palladium catalyst to cause partial racemization at branched-chain stereogenic centers in the course of hydrogenation. [9] Our results, however, suggest that plati- 
Bioassay and Conclusion
The four stereoisomers of 6-acetoxy-19-methylnonacosane (1) were bioassayed in doseϪresponse tests at 0.1 to 6 µg against male screwworm flies ( Figure 2 ). The activities of the isomers were statistically indistinguishable. Full pheromone activity was generally 66% and above at 1 µg and above 73% at 2 µg, with some isomers having 100% responses at 4 µg and 6 µg. Many responses above 2 µg were 93%. The pheromone activity of the synthetic stereoisomers of 1 was therefore quite good, yielding 50% response at 0.5 µg. The stereochemistry of 1, however, was not significant for bioactivity, indicating that the stereochemistry was not critical for the recognition of 1 by the pheromone receptors. In this regard, some other examples are known, [10] especially in the case of 3,11-dimethylnonacosan-2-one, the female sex pheromone of the German cockroach (Blattella germanica). [11] The absolute configuration of the naturally occurring 1 remains obscure. Detailed biological results will be published separately by one of us (D.A.C.).
Another practically important conclusion is the danger of using platinum oxide as a catalyst for hydrogenation of unsaturated and optically active secondary alcohols. The platinum catalyst will diminish the enantiomeric purity at the asymmetric carbon atom bearing a hydroxy group.
Experimental Section
General: IR: Horiba FT-720. 1 H NMR: Varian Mercury-300 (300 MHz) (TMS at δ ϭ 0.00 pm or CHCl 3 at δ ϭ 7.26 ppm as internal standard). 
(S)-11-Methylhenicosan-1-ol [(S)-10]:
A solution of THPO(CH 2 ) 7 Br (7.8 g, 25 mmol) in dry THF (30 mL) was added to Mg (800 mg, 33 mmol) and a small piece of I 2 (ca. 5 mg) with stirring under Ar to make a Grignard reagent. The generated Grignard reagent was added dropwise to a stirred and cooled solution of (S)-8 [ca. 3.4 g; prepared from (S)-4-methyltetradecan-1-ol (1.8 g, 7.9 mmol)] in THF (40 mL) at Ϫ78°C under Ar. A solution of Li 2 CuCl 4 in THF (0.1 , 1.0 mL) was added to the mixture. The stirring was continued overnight with gradual warming to room temperature (22°C). The mixture was poured into ice and satd. NH 4 Cl solution, and extracted with hexane. The hexane solution was washed with brine, dried (MgSO 4 ) and concentrated in vacuo to give a crude oil (7.9 g) containing (S)-9. This was dissolved in MeOH (80 mL), and acidified with p-TsOH·H 2 O (150 mg, 0.8 mmol). After stirring for two days at room temperature (22°C), the mixture was neutralized with NaHCO 3 aq. solution, and concentrated in vacuo to remove MeOH. The residue was extracted with Et 2 O. The organic extract was washed with water and brine, dried (MgSO 4 ) and concentrated in vacuo to give a crude oil (5.2 g). This was chromatographed over SiO 2 (60 g). Elution with hexane/EtOAc (60:1) gave (S)-10 (1. 8 
(6S,19S)-19-Methylnonacos-7-yn-6-ol [(6S,19S)-15] via (6S,19S)-14:
A solution of nBuLi in hexane (1.6 , 1.8 mL, 2.9 mmol) was added to a stirred and cooled solution of (S)-13 (673 mg, 2.8 mmol) in dry THF (5 mL) and HMPA (1 mL) at Ϫ40°C under Ar. The mixture was stirred at 0°C for 30 min, and then cooled to Ϫ40°C. To this was added with stirring and cooling at Ϫ40°C a solution of (S)-11 (510 mg, 1.2 mmol) in THF (5 mL). The mixture was stirred overnight at room temperature, poured into ice/NH 4 Cl solution and extracted with hexane/Et 2 O. The extract was washed with H 2 O and brine, dried (MgSO 4 ) and concentrated in vacuo to give 570 mg of crude (6S,19S)-14 as an oil, which was dissolved in THF (4 mL). TBAF (l M in THF, 4 mL) was added to the solution above and the mixture was left to stand for three days at room temperature. EtOAc. PtO 2 (40 mg) was added to a solution of (6S,19S)-15 (120 mg, 0.28 mmol) in hexane (5 mL), and the suspension was vigorously stirred for 2.5 h under H 2 at room temperature. Pt black finally precipitated by coagulation. The catalyst was filtered off, and the filtrate was concentrated in vacuo. The residue was chromatographed on SiO 2 (5 g 
19-Methylnonacos-7-yn-6-ol (15) via the Dianion of 12. (i) (6S,19S)-15:
The dianion of (S)-12 was prepared by addition of a solution of nBuLi in hexane (1.6 , 8.5 mL, 12 mmol) to a stirred and cooled solution of (S)-12 (760 mg, 6 mmol) in THF (7.5 mL) and HMPA (1.5 mL) at Ϫ40°C under Ar. The mixture was stirred at 0°C for 20 min. The stirred solution was then cooled to Ϫ78°C. To this mixture was added dropwise a solution of (S)-11 (720 mg, 1.6 mmol) in THF (7.5 mL) with stirring and cooling at Ϫ78°C. After stirring at Ϫ78°C for 20 min, the stirred mixture was left to stand overnight with gradual warming to room temperature (22°C ). It was then poured into ice/NH 4 16 or 15] , the mixture was kept at room temperature for more than 10 h. An aliquot was then loaded onto a silica gel TLC plate (10 cm length, Silicagel 60 F 254 , Art Ϫ 5744, Merck) and developed with hexane/EtOAc (4:1, v/v). The target spot 18 or 19 detected by fluorescence was collected, packed in a Pasteur pipette and eluted with EtOAc/EtOH (4:1, v/v). After evaporation of the solvent with a N 2 gas stream, the residue was dissolved in MeOH and used for an HPLC analysis. For preparation of 17, which is not yet commercially available, see ref. [12] .
HPLC Separation:
The derivatives 18 or 19 were separated on a reversed-phase column (Develosil C30-UG-3, 3µm, (4.6 mm I. D. 
